Device Trial Radar · NCT07932561
Expiratory Muscle Strength Training for People With Parkinson's Disease
Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
80
Planned (sponsor's estimate)
Start
Apr 8, 2024
Primary completion
Sep 30, 2028
Study completion Dec 31, 2028
Sponsor
- Lead sponsor
- Karolinska InstitutetAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Region Stockholm
- First posted
- Nov 12, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is a Post-Market Clinical Follow-up (PMCF) randomized controlled trial of a CE-marked device used in routine clinical practice. The goal of this study is to investigate whether Expiratory Muscle Strength Training (EMST) improves voice, speech, breathing, and swallowing function in people with Parkinson's disease. The research questions are: Does EMST improve voice, speech, breathing, and swallowing in people with Parkinson's disease, as measured by clinical tests, immediately after the training period and three months later? Does EMST lead to meaningful improvements in voice, speech, breathing, and swallowing problems as reported by people with Parkinson's disease immediately after the training period and three months later? Do the effects of EMST differ according to disease severity? Researchers will compare participants who receive EMST with participants in a passive control group to determine whether EMST improves voice, speech, breathing, and swallowing function. Participants will: Be randomly assigned to either an EMST group or a passive control group. Complete a structured EMST training program, if assigned to the intervention group. Attend study visits for assessments of voice, speech, breathing, and swallowing function. Undergo clinical tests and complete study-related evaluations throughout the study. Be monitored for any device-related or study-related adverse events.
Conditions
- PARKINSON DISEASE (Disorder)
Interventions
Expiratory Muscle Strength Training (EMST)Device
Expiratory Muscle Strength Training (EMST) will be performed using a CE-marked, calibrated handheld threshold device that provides a fixed expiratory resistance. Participants will complete 5 sets of 5 forceful expiratory breaths per day, 5 days per week, for 5 weeks. The training load will be individually calibrated and adjusted weekly based on each participant's performance to maintain an appropriate training intensity. The intervention is designed to strengthen expiratory and submental muscles involved in respiration, phonation, speech, and swallowing.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Sound Pressure Level/SPLTime frame: Assessment Time-points: (i) Baseline (two baseline measurements obtained 5 weeks apart), (ii) immediately post-intervention, and (iii) 3-month follow-up.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Department of Speech and Language Therapy, Danderyd Hospital
Stockholm, Stockholm County, Sweden · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.